Synopsis
0
JDMF
0
EU WC
0
KDMF
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Fillers, Diluents & Binders
Direct Compression
Chewable & Orodispersible Aids
Taste Masking
Co-Processed Excipients
Parenteral
Digital Content
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
90
PharmaCompass offers a list of Chlortetracycline Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Chlortetracycline Hydrochloride manufacturer or Chlortetracycline Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Chlortetracycline Hydrochloride manufacturer or Chlortetracycline Hydrochloride supplier.
PharmaCompass also assists you with knowing the Chlortetracycline Hydrochloride API Price utilized in the formulation of products. Chlortetracycline Hydrochloride API Price is not always fixed or binding as the Chlortetracycline Hydrochloride Price is obtained through a variety of data sources. The Chlortetracycline Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Aureomycin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Aureomycin, including repackagers and relabelers. The FDA regulates Aureomycin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Aureomycin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Aureomycin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Aureomycin supplier is an individual or a company that provides Aureomycin active pharmaceutical ingredient (API) or Aureomycin finished formulations upon request. The Aureomycin suppliers may include Aureomycin API manufacturers, exporters, distributors and traders.
click here to find a list of Aureomycin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Aureomycin DMF (Drug Master File) is a document detailing the whole manufacturing process of Aureomycin active pharmaceutical ingredient (API) in detail. Different forms of Aureomycin DMFs exist exist since differing nations have different regulations, such as Aureomycin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Aureomycin DMF submitted to regulatory agencies in the US is known as a USDMF. Aureomycin USDMF includes data on Aureomycin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Aureomycin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Aureomycin suppliers with USDMF on PharmaCompass.
A Aureomycin CEP of the European Pharmacopoeia monograph is often referred to as a Aureomycin Certificate of Suitability (COS). The purpose of a Aureomycin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Aureomycin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Aureomycin to their clients by showing that a Aureomycin CEP has been issued for it. The manufacturer submits a Aureomycin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Aureomycin CEP holder for the record. Additionally, the data presented in the Aureomycin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Aureomycin DMF.
A Aureomycin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Aureomycin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Aureomycin suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Aureomycin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Aureomycin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Aureomycin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Aureomycin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Aureomycin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Aureomycin suppliers with NDC on PharmaCompass.
Aureomycin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Aureomycin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Aureomycin GMP manufacturer or Aureomycin GMP API supplier for your needs.
A Aureomycin CoA (Certificate of Analysis) is a formal document that attests to Aureomycin's compliance with Aureomycin specifications and serves as a tool for batch-level quality control.
Aureomycin CoA mostly includes findings from lab analyses of a specific batch. For each Aureomycin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Aureomycin may be tested according to a variety of international standards, such as European Pharmacopoeia (Aureomycin EP), Aureomycin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Aureomycin USP).
